Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07446322 |
| Title | FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Oncolytics Biotech |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Central Alabama Research | RECRUITING | Homewood | Alabama | 35209 | United States | Details |
| Summit Health Cancer Center | RECRUITING | Florham Park | New Jersey | 07932 | United States | Details |
| Gabrail Cancer Center | RECRUITING | Canton | Ohio | 44718 | United States | Details |